UCB signs a new EUR 1.5 billion credit facility
(Thomson Reuters ONE) - Brussels, Belgium, December 15 2009 - 8:30 (CET). Regulatedinformation. - UCB SA ("UCB" or the "Company") is pleased to announcethe signing of its new EUR 1.5 billion revolving credit facility.The purpose of the facility is to refinance the Company's EUR 4billion banking facility arranged in connection with the 2006acquisition of Schwarz Pharma, which has since amortised toEUR 3.3 billion and is due to mature in October 2011.The new facility has a three year maturity and a one year extensionoption.The margin and other terms and conditions are customary for similarinvestment grade loan facilities.Prior to arranging this new facility, UCB has successfully issuedthree bonds with different maturities raising EUR 1.75 billion intotal from debt capital markets. The proceeds from these bonds willalso be used to refinance the existing credit facility.Detlef Thielgen, Chief Financial Officer of UCB, commented, "We arevery pleased to have successfully completed this new facility. It isthe next step in our strategy to firmly establish UCB as a globalbiopharma industry leader. The fact that all banks originally invitedinto this transaction have signed up to the agreement, underscoresthe confidence which the loan and debt capital markets have shown inUCB throughout this refinancing process."For further informationRichard Simpson, Investor Relations, UCBT+32.2.559.9494, richard.simpson(at)ucb.comMichael Tuck-Sherman, Investor Relations, UCBT +32.2.559.9712, michael.tuck-sherman(at)ucb.comNancy Nackaerts, External Communications, UCBT +32.473.864.414, nancy.nackaerts(at)ucb.comAbout UCBUCB, Brussels, Belgium (www.ucb.com) is a biopharmaceutical companydedicated to the research, development and commercialization ofinnovative medicines with a focus on the fields of central nervoussystem and immunology disorders. Employing approximately 10 000people in over 40 countries, UCB generated revenue of 3.6 billioneuro in 2008. UCB is listed on Euronext Brussels (symbol: UCB).Forward looking statementThis press release contains forward-looking statements based oncurrent plans, estimates and beliefs of management. Such statementsare subject to risks and uncertainties that may cause actual resultsto be materially different from those that may be implied by suchforward-looking statements contained in this press release. Importantfactors that could result in such differences include: changes ingeneral economic, business and competitive conditions, effects offuture judicial decisions, changes in regulation, exchange ratefluctuations and hiring and retention of its employees.For the pdf-version of this press release, please click on the linkbelow:http://hugin.info/133973/R/1361081/332384.pdfThis announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.
Datum: 15.12.2009 - 08:32 Uhr
Sprache: Deutsch
News-ID 9611
Anzahl Zeichen: 0
contact information:
Town:
London
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 579 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"UCB signs a new EUR 1.5 billion credit facility"
steht unter der journalistisch-redaktionellen Verantwortung von
UCB (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
